[Beating heart cells--targeted diagnostics, individual optimization of therapy and tailored cell therapies]

Esko Kankuri1, Ari Harjula, Tommi Pätilä

  • 1Helsingin yliopisto.

Duodecim; Laaketieteellinen Aikakauskirja
|January 7, 2015
PubMed

Insights

Heart damage from myocardial infarction is permanent due to the heart's limited repair capacity. Research into stem cells for cardiac repair shows low efficacy, but embryonic and iPS cells hold future promise.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Stem Cell Biology

Context:

  • Myocardial infarction leads to irreversible heart scarring and functional decline.
  • Current stem cell therapies for cardiac repair exhibit limited efficacy.
  • Embryonic stem cells and induced pluripotent stem cells (iPS cells) are key research areas.

Purpose:

  • To explore the potential of stem cells in repairing myocardial damage.
  • To investigate the efficacy of various stem cell types in cardiac regeneration.
  • To evaluate the future applications of stem cell-derived cardiomyocytes.

Summary:

  • The heart's inability to self-repair after myocardial infarction necessitates therapeutic interventions.
  • While adult stem cell treatments have shown low efficacy, embryonic stem cells and iPS cells present significant research opportunities.
  • Stem cell-derived cardiomyocytes are crucial for advancing drug development, safety testing, and personalized medicine.

Impact:

  • Advances in stem cell research could lead to novel treatments for heart disease.
  • Improved cardiac repair strategies may restore heart function after infarction.
  • The use of stem cell-derived cells promises to revolutionize pharmaceutical testing and patient-specific treatments.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K